CLINICAL TRIAL SUMMARY

MDACC Study No:2010-0489 (clinicaltrials.gov NCT No: NCT01063114)
Title:A Phase II Study of Proton beam radiotherapy for medulloblastoma and
pineoblastoma: an assessment of acute toxicity and long term neurocognitive,
neuroendocrine and ototoxicity outcomes
Principal Investigator:Anita Mahajan
Treatment Agent:Proton Therapy
Study Status:Open
Study Description:The goal of this clinical research study is to learn about the safety of giving
proton beam radiation therapy to the brain and spinal cord in patients with
medulloblastoma or pineoblastoma who are between the ages of 3 and 25.
Researchers want to learn if proton therapy has fewer short and long-term side
effects than a more standard type of radiation therapy (photon beam radiation
therapy).

Hide details for General InformationGeneral Information

Disease Group:CNS
Phase of Study:Phase II
Treatment Agents:Proton Therapy
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:National Institute of Health (NIH)
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Anita Mahajan
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults